North America Interventional Cardiology Market is expected to reach US$ 11.98 billion by 2033 | Top Companies - Medtronic, Terumo Corporation, Abbott.

Market Size and Growth:

The North America Interventional Cardiology Market Size reached US$ 7.04 billion in 2024 and is expected to reach US$ 11.98 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033. The Market is rising mainly because cardiovascular diseases are increasing across the region and hospitals are rapidly adopting advanced minimally invasive technologies that improve outcomes and reduce recovery time. According to DataM Intelligence

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/north-america-interventional-cardiology-market?sz

The North America Interventional Cardiology Market refers to the ecosystem of minimally invasive cardiovascular procedures, devices, technologies, and services used to diagnose and treat coronary artery disease, structural heart disorders, and vascular conditions. It includes angioplasty, stents, catheters, imaging systems, and supporting clinical solutions adopted across hospitals and cardiac centers to improve patient outcomes and reduce procedural risks.

Industry Recent Developments: United States

✅ November 2025: Rising adoption of advanced imaging techniques such as 3D echocardiography, OCT, and IVUS is improving procedural success rates in structural heart disease interventions. Devices like transcatheter heart valves and image-guided navigation systems have enhanced precision and outcomes.

✅ October 2025: Terumo Interventional Systems commercially launched its R2P NaviCross peripheral support catheter in the U.S., expanding their radial-to-peripheral (R2P) product line.

✅ September 2025: BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter to improve guidewire support during percutaneous coronary interventions. This complements IMDS's portfolio of interventional devices being marketed in the U.S.

Industry Recent Developments: Japan

✅ November 2025: Collaborations between Japanese companies and North American partners are deepening, including a co-development project between Osaka University and a U.S. biotech firm to create smart microcatheters capable of precise drug delivery within coronary arteries.

✅ October 2025: Increased government investments in healthcare modernization and adoption of minimally invasive interventional cardiology techniques in Japan have accelerated growth in the cardiology devices market.

✅ September 2025: Japanese firms are focusing on innovation in AI integration for imaging and interventions, contributing to better pre-operative planning and real-time procedural decision-making in cardiovascular treatments.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/north-america-interventional-cardiology-market?sz

FDA / US Device Actions in 2025:

✅ Shockwave IVL - PMA supplement decision (C2 Aero catheter): FDA docket shows a PMA supplement for the Shockwave Intravascular Lithotripsy (IVL) System with the C2 Aero coronary catheter with a decision date June 10, 2025 (PMA supplement record).

✅ Why it matters: IVL is a key technology for treating severely calcified coronary lesions; any expanded/updated clearance or new catheter variants materially affect procedural choice and vendor positioning.

✅ New/updated coronary stent and DES listings seen in FDA records during 2025: FDA device listings and PMA supplement records show activity for coronary drug-eluting stents and related systems (new product listings / supplements appeared in 2025). (FDA product classification and establishment listings).

Major Mergers & Acquisitions (2025):

✅ Boston Scientific - Bolt Medical (IVL): Boston Scientific agreed to acquire the remaining stake of Bolt Medical (deal announced Jan 8, 2025; up to ~$900M in total consideration). This strengthened Boston Scientific's intravascular lithotripsy / calcified-lesion portfolio.

✅ Broader 2025 medtech M&A activity / consolidation: Roundups of 2025 medtech M&A list multiple interventional cardiology-relevant deals (acquisitions expanding imaging, IVL, and catheter portfolios). These deal summaries show continuing consolidation among big-cap OEMs.

Regulatory & Clinical-guidance Landscape (North America):

✅ ACC/AHA / professional guideline updates (2025): Major professional societies published 2025 guideline updates affecting acute coronary syndrome / interventional practice - these influence device adoption, indications, and standard of care. (2025 ACC/AHA guideline citations).

✅ Canada (Health Canada) - standards updates (2025): Health Canada's list of recognized standards for medical devices was published/updated (effective Jan 27, 2025), which affects conformity paths / recognized test standards for devices sold in Canada.

Major Key Players:

Medtronic
Terumo Corporation
Boston Scientific Corporation
Abbott.
Canon Medical Systems Corporation
Teleflex Incorporated.
B. Braun SE
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
Cook Medical.

Segments Covered in the North America Interventional Cardiology Market:

By Modality: Stents, Catheters, Balloons, Guidewires, Imaging Systems, Thrombectomy Systems, Atherectomy Systems, Closure Devices, Chronic Total Occlusion Systems (CTO), Others.

By End-User: Hospitals, CATH Labs, Ambulatory Surgical Centers, Others.

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=north-america-interventional-cardiology-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, North America Interventional Cardiology market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the North America Interventional Cardiology Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The North America Interventional Cardiology market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the North America Interventional Cardiology Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of North America Interventional Cardiology market?

➠ Who are the global key manufacturers of the North America Interventional Cardiology Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the North America Interventional Cardiology market opportunities and threats faced by the vendors in the global North America Interventional Cardiology Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the North America Interventional Cardiology market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.